ReP USP - Resultado da busca

Artigo de periodico
Effects of JL13, a pyridobenzoxazepine compound, in dopaminergic and glutamatergic models of antipsychotic activity (2021)
Andrade, Yane C. P.; Ropke, Jivago; Viana, Thércia G.; Fanelli, Chiara; Minaldi, Elisa; Batista, Luara A.; Issy, Ana Carolina; Del Bel, Elaine Aparecida ; Rodrigues, Lívia C. M.; Liégeois, Jean-François; Moreira, Fabrício A.
Fonte: Behavioural Pharmacology. Unidade: FORP
Assuntos: TRANSTORNOS PSICÓTICOS, FÁRMACOS (SISTEMA NERVOSO CENTRAL), ANTIPSICÓTICOS, FARMACOLOGIA, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Yane C. P. et al. Effects of JL13, a pyridobenzoxazepine compound, in dopaminergic and glutamatergic models of antipsychotic activity. Behavioural Pharmacology, v. 32, n. 1, p. 2-8, 2021Tradução . . Disponível em: https://doi.org/10.1097/FBP.0000000000000595. Acesso em: 26 out. 2025.
APA
Andrade, Y. C. P., Ropke, J., Viana, T. G., Fanelli, C., Minaldi, E., Batista, L. A., et al. (2021). Effects of JL13, a pyridobenzoxazepine compound, in dopaminergic and glutamatergic models of antipsychotic activity. Behavioural Pharmacology, 32( 1), 2-8. doi:10.1097/FBP.0000000000000595
NLM
Andrade YCP, Ropke J, Viana TG, Fanelli C, Minaldi E, Batista LA, Issy AC, Del Bel EA, Rodrigues LCM, Liégeois J-F, Moreira FA. Effects of JL13, a pyridobenzoxazepine compound, in dopaminergic and glutamatergic models of antipsychotic activity [Internet]. Behavioural Pharmacology. 2021 ; 32( 1): 2-8.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0000000000000595
Vancouver
Andrade YCP, Ropke J, Viana TG, Fanelli C, Minaldi E, Batista LA, Issy AC, Del Bel EA, Rodrigues LCM, Liégeois J-F, Moreira FA. Effects of JL13, a pyridobenzoxazepine compound, in dopaminergic and glutamatergic models of antipsychotic activity [Internet]. Behavioural Pharmacology. 2021 ; 32( 1): 2-8.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0000000000000595
Artigo de periodico
A valepotriate-enriched fraction from Valeriana glechomifolia decreases DNA methylation and up-regulate TrkB receptors in the hippocampus of mice (2020)
Müller, Liz G.; Biojone, Caroline ; Sales, Amanda Juliana ; Betti, Andresa H.; Herzfeldt, Vivian; Wegener, Sâmia Regiane Lourenço Joca ; Rates, Stela M. K.
Fonte: Behavioural Pharmacology. Unidades: FCFRP, FMRP
Assuntos: METILAÇÃO DE DNA, HIPOCAMPO, ALCALOIDES, EXTRATOS (FORMAS FARMACÊUTICAS), CÓRTEX PRÉ-FRONTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MÜLLER, Liz G. et al. A valepotriate-enriched fraction from Valeriana glechomifolia decreases DNA methylation and up-regulate TrkB receptors in the hippocampus of mice. Behavioural Pharmacology, v. 31, n. 4, p. 333-342, 2020Tradução . . Disponível em: https://doi.org/10.1097/FBP.0000000000000534. Acesso em: 26 out. 2025.
APA
Müller, L. G., Biojone, C., Sales, A. J., Betti, A. H., Herzfeldt, V., Wegener, S. R. L. J., & Rates, S. M. K. (2020). A valepotriate-enriched fraction from Valeriana glechomifolia decreases DNA methylation and up-regulate TrkB receptors in the hippocampus of mice. Behavioural Pharmacology, 31( 4), 333-342. doi:10.1097/FBP.0000000000000534
NLM
Müller LG, Biojone C, Sales AJ, Betti AH, Herzfeldt V, Wegener SRLJ, Rates SMK. A valepotriate-enriched fraction from Valeriana glechomifolia decreases DNA methylation and up-regulate TrkB receptors in the hippocampus of mice [Internet]. Behavioural Pharmacology. 2020 ; 31( 4): 333-342.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0000000000000534
Vancouver
Müller LG, Biojone C, Sales AJ, Betti AH, Herzfeldt V, Wegener SRLJ, Rates SMK. A valepotriate-enriched fraction from Valeriana glechomifolia decreases DNA methylation and up-regulate TrkB receptors in the hippocampus of mice [Internet]. Behavioural Pharmacology. 2020 ; 31( 4): 333-342.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0000000000000534
Artigo de periodico
Attenuation of glutamatergic and nitrergic system contributes to the antidepressant-like effect induced by capsazepine in the forced swimming test (2019)
Sartim, Ariandra Guerini; Brito, Bianca M.; Nunes, Pedro Henrique Gobira; Wegener, Sâmia Regiane Lourenço Joca
Fonte: Behavioural Pharmacology. Unidade: FCFRP
Assuntos: ANTIDEPRESSIVOS, NATAÇÃO, CAMUNDONGOS, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SARTIM, Ariandra Guerini et al. Attenuation of glutamatergic and nitrergic system contributes to the antidepressant-like effect induced by capsazepine in the forced swimming test. Behavioural Pharmacology, v. 30, n. 1, p. 59-66, 2019Tradução . . Disponível em: https://doi.org/10.1097/FBP.0000000000000416. Acesso em: 26 out. 2025.
APA
Sartim, A. G., Brito, B. M., Nunes, P. H. G., & Wegener, S. R. L. J. (2019). Attenuation of glutamatergic and nitrergic system contributes to the antidepressant-like effect induced by capsazepine in the forced swimming test. Behavioural Pharmacology, 30( 1), 59-66. doi:10.1097/FBP.0000000000000416
NLM
Sartim AG, Brito BM, Nunes PHG, Wegener SRLJ. Attenuation of glutamatergic and nitrergic system contributes to the antidepressant-like effect induced by capsazepine in the forced swimming test [Internet]. Behavioural Pharmacology. 2019 ; 30( 1): 59-66.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0000000000000416
Vancouver
Sartim AG, Brito BM, Nunes PHG, Wegener SRLJ. Attenuation of glutamatergic and nitrergic system contributes to the antidepressant-like effect induced by capsazepine in the forced swimming test [Internet]. Behavioural Pharmacology. 2019 ; 30( 1): 59-66.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0000000000000416
Artigo de periodico
Anti-NGF treatment can reduce chronic neuropathic pain by changing peripheral mediators and brain activity in rats (2019)
Silva, Joyce Teixeira da; Evangelista, Bianca G.; Venega, Rafael Augusto Galdino ; Seminowicz, David A.; Chacur, Marucia
Fonte: Behavioural Pharmacology. Unidade: ICB
Assuntos: ANATOMIA, CATALEPSIA, ANTIPSICÓTICOS, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Joyce Teixeira da et al. Anti-NGF treatment can reduce chronic neuropathic pain by changing peripheral mediators and brain activity in rats. Behavioural Pharmacology, v. 30, n. 1, p. 79-88, 2019Tradução . . Disponível em: https://doi.org/10.1097/FBP.0000000000000422. Acesso em: 26 out. 2025.
APA
Silva, J. T. da, Evangelista, B. G., Venega, R. A. G., Seminowicz, D. A., & Chacur, M. (2019). Anti-NGF treatment can reduce chronic neuropathic pain by changing peripheral mediators and brain activity in rats. Behavioural Pharmacology, 30( 1), 79-88. doi:10.1097/FBP.0000000000000422
NLM
Silva JT da, Evangelista BG, Venega RAG, Seminowicz DA, Chacur M. Anti-NGF treatment can reduce chronic neuropathic pain by changing peripheral mediators and brain activity in rats [Internet]. Behavioural Pharmacology. 2019 ;30( 1): 79-88.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0000000000000422
Vancouver
Silva JT da, Evangelista BG, Venega RAG, Seminowicz DA, Chacur M. Anti-NGF treatment can reduce chronic neuropathic pain by changing peripheral mediators and brain activity in rats [Internet]. Behavioural Pharmacology. 2019 ;30( 1): 79-88.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0000000000000422
Artigo de periodico
Participation of hippocampal nitric oxide synthase and soluble guanylate cyclase in the modulation of behavioral responses elicited by the rat forced swimming test (2017)
Sales, Amanda J.; Hiroaki-Sato, Vinícius A.; Joca, Sâmia Regiane Lourenço
Fonte: Behavioural Pharmacology. Unidade: FCFRP
Assuntos: FARMACOLOGIA, ÓXIDO NÍTRICO, HIPOCAMPO, ANTIDEPRESSIVOS, ESTRESSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALES, Amanda J. e HIROAKI-SATO, Vinícius A. e JOCA, Sâmia Regiane Lourenço. Participation of hippocampal nitric oxide synthase and soluble guanylate cyclase in the modulation of behavioral responses elicited by the rat forced swimming test. Behavioural Pharmacology, v. 28, n. 1, p. 19-29, 2017Tradução . . Disponível em: https://doi.org/10.1097/FBP.0000000000000263. Acesso em: 26 out. 2025.
APA
Sales, A. J., Hiroaki-Sato, V. A., & Joca, S. R. L. (2017). Participation of hippocampal nitric oxide synthase and soluble guanylate cyclase in the modulation of behavioral responses elicited by the rat forced swimming test. Behavioural Pharmacology, 28( 1), 19-29. doi:10.1097/FBP.0000000000000263
NLM
Sales AJ, Hiroaki-Sato VA, Joca SRL. Participation of hippocampal nitric oxide synthase and soluble guanylate cyclase in the modulation of behavioral responses elicited by the rat forced swimming test [Internet]. Behavioural Pharmacology. 2017 ; 28( 1): 19-29.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0000000000000263
Vancouver
Sales AJ, Hiroaki-Sato VA, Joca SRL. Participation of hippocampal nitric oxide synthase and soluble guanylate cyclase in the modulation of behavioral responses elicited by the rat forced swimming test [Internet]. Behavioural Pharmacology. 2017 ; 28( 1): 19-29.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0000000000000263
Artigo de periodico
A serotonergic deficit in the dorsal periaqueductal gray matter may underpin enhanced panic-like behavior in diabetic rats (2017)
Gambeta, Eder; Sestile, Caio C.; Fogaça, Manoela V.; Guimarães, Francisco Silveira; Audi, Elisabeth A.; Cunha, Joice M. da; Zangrossi Júnior, Hélio; Yamashita, Paula Shimene de Melo; Zanoveli, Janaina M.
Fonte: Behavioural Pharmacology. Unidade: FMRP
Assuntos: ANSIEDADE, DIABETES MELLITUS, MODELOS ANIMAIS DE DOENÇAS, RECEPTORES DE SEROTONINA, SUBSTÂNCIA CINZENTA PERIAQUEDUTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GAMBETA, Eder et al. A serotonergic deficit in the dorsal periaqueductal gray matter may underpin enhanced panic-like behavior in diabetic rats. Behavioural Pharmacology, v. 28, n. 7, p. 558-564, 2017Tradução . . Disponível em: https://doi.org/10.1097/fbp.0000000000000332. Acesso em: 26 out. 2025.
APA
Gambeta, E., Sestile, C. C., Fogaça, M. V., Guimarães, F. S., Audi, E. A., Cunha, J. M. da, et al. (2017). A serotonergic deficit in the dorsal periaqueductal gray matter may underpin enhanced panic-like behavior in diabetic rats. Behavioural Pharmacology, 28( 7), 558-564. doi:10.1097/fbp.0000000000000332
NLM
Gambeta E, Sestile CC, Fogaça MV, Guimarães FS, Audi EA, Cunha JM da, Zangrossi Júnior H, Yamashita PS de M, Zanoveli JM. A serotonergic deficit in the dorsal periaqueductal gray matter may underpin enhanced panic-like behavior in diabetic rats [Internet]. Behavioural Pharmacology. 2017 ; 28( 7): 558-564.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/fbp.0000000000000332
Vancouver
Gambeta E, Sestile CC, Fogaça MV, Guimarães FS, Audi EA, Cunha JM da, Zangrossi Júnior H, Yamashita PS de M, Zanoveli JM. A serotonergic deficit in the dorsal periaqueductal gray matter may underpin enhanced panic-like behavior in diabetic rats [Internet]. Behavioural Pharmacology. 2017 ; 28( 7): 558-564.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/fbp.0000000000000332
Artigo de periodico
Early social isolation increases persistence of alcohol-seeking behavior in alcohol-related contexts (2016)
Mijares, Miriam Garcia
Fonte: Behavioural Pharmacology. Unidade: IP
Assuntos: COMPORTAMENTO, ÁLCOOL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIJARES, Miriam Garcia. Early social isolation increases persistence of alcohol-seeking behavior in alcohol-related contexts. Behavioural Pharmacology, v. 27, p. 185–191, 2016Tradução . . Disponível em: https://doi.org/10.1097/fbp.0000000000000213. Acesso em: 26 out. 2025.
APA
Mijares, M. G. (2016). Early social isolation increases persistence of alcohol-seeking behavior in alcohol-related contexts. Behavioural Pharmacology, 27, 185–191. doi:10.1097/fbp.0000000000000213
NLM
Mijares MG. Early social isolation increases persistence of alcohol-seeking behavior in alcohol-related contexts [Internet]. Behavioural Pharmacology. 2016 ;27 185–191.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/fbp.0000000000000213
Vancouver
Mijares MG. Early social isolation increases persistence of alcohol-seeking behavior in alcohol-related contexts [Internet]. Behavioural Pharmacology. 2016 ;27 185–191.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/fbp.0000000000000213
Artigo de periodico
Maternal treatment with picrotoxin in late pregnancy improved female sexual behavior but did not alter male sexual behavior of offspring (2013)
Bernardi, Maria Martha; Scanzerla, Kayne K; Chamlian, Mayra; Teodorov, Elizabeth; Felicio, Luciano Freitas
Fonte: Behavioural Pharmacology. Unidade: FMVZ
Assuntos: ANTAGONISTAS, COMPORTAMENTO SEXUAL ANIMAL (FÊMEA;MACHO), PERÍODO PERINATAL, PRENHEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERNARDI, Maria Martha et al. Maternal treatment with picrotoxin in late pregnancy improved female sexual behavior but did not alter male sexual behavior of offspring. Behavioural Pharmacology, v. 24, n. 4, p. 282-290, 2013Tradução . . Disponível em: https://doi.org/10.1097/FBP.0b013e3283633662. Acesso em: 26 out. 2025.
APA
Bernardi, M. M., Scanzerla, K. K., Chamlian, M., Teodorov, E., & Felicio, L. F. (2013). Maternal treatment with picrotoxin in late pregnancy improved female sexual behavior but did not alter male sexual behavior of offspring. Behavioural Pharmacology, 24( 4), 282-290. doi:10.1097/FBP.0b013e3283633662
NLM
Bernardi MM, Scanzerla KK, Chamlian M, Teodorov E, Felicio LF. Maternal treatment with picrotoxin in late pregnancy improved female sexual behavior but did not alter male sexual behavior of offspring [Internet]. Behavioural Pharmacology. 2013 ; 24( 4): 282-290.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0b013e3283633662
Vancouver
Bernardi MM, Scanzerla KK, Chamlian M, Teodorov E, Felicio LF. Maternal treatment with picrotoxin in late pregnancy improved female sexual behavior but did not alter male sexual behavior of offspring [Internet]. Behavioural Pharmacology. 2013 ; 24( 4): 282-290.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0b013e3283633662
Artigo de periodico
Intrahippocampal injection of brain-derived neurotrophic factor increases anxiety-related, but not panic-related defensive responses: involvement of serotonin (2012)
Casarotto, Plinio C.; Bortoli, Valquiria C. de; Zangrossi Junior, Helio
Fonte: Behavioural Pharmacology. Unidade: FMRP
Assuntos: ANSIEDADE, MECANISMOS DE DEFESA, RECEPTORES DE SEROTONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASAROTTO, Plinio C. e BORTOLI, Valquiria C. de e ZANGROSSI JUNIOR, Helio. Intrahippocampal injection of brain-derived neurotrophic factor increases anxiety-related, but not panic-related defensive responses: involvement of serotonin. Behavioural Pharmacology, v. 23, n. 1, p. 80-88, 2012Tradução . . Disponível em: https://doi.org/10.1097/FBP.0b013e32834ecb14. Acesso em: 26 out. 2025.
APA
Casarotto, P. C., Bortoli, V. C. de, & Zangrossi Junior, H. (2012). Intrahippocampal injection of brain-derived neurotrophic factor increases anxiety-related, but not panic-related defensive responses: involvement of serotonin. Behavioural Pharmacology, 23( 1), 80-88. doi:10.1097/FBP.0b013e32834ecb14
NLM
Casarotto PC, Bortoli VC de, Zangrossi Junior H. Intrahippocampal injection of brain-derived neurotrophic factor increases anxiety-related, but not panic-related defensive responses: involvement of serotonin [Internet]. Behavioural Pharmacology. 2012 ; 23( 1): 80-88.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0b013e32834ecb14
Vancouver
Casarotto PC, Bortoli VC de, Zangrossi Junior H. Intrahippocampal injection of brain-derived neurotrophic factor increases anxiety-related, but not panic-related defensive responses: involvement of serotonin [Internet]. Behavioural Pharmacology. 2012 ; 23( 1): 80-88.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0b013e32834ecb14
Artigo de periodico
Maternal exposure to picrotoxin modifies the response of the GABAA receptor during sexual behavior of adult male rat offspring (2012)
Bernardi, Maria Martha; Kirsten, Thiago Berti; Teodorov, Elizabeth; Baso, Ana Cristina Zanandréa; Prosdócimi, Fábio César; Felicio, Luciano Freitas
Fonte: Behavioural Pharmacology. Unidade: FMVZ
Assuntos: CÉREBRO (DESENVOLVIMENTO), PERÍODO PERINATAL, RATOS, COMPORTAMENTO SEXUAL ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERNARDI, Maria Martha et al. Maternal exposure to picrotoxin modifies the response of the GABAA receptor during sexual behavior of adult male rat offspring. Behavioural Pharmacology, v. 23, n. 7, p. 703-708, 2012Tradução . . Disponível em: https://doi.org/10.1097/FBP.0b013e3283586072. Acesso em: 26 out. 2025.
APA
Bernardi, M. M., Kirsten, T. B., Teodorov, E., Baso, A. C. Z., Prosdócimi, F. C., & Felicio, L. F. (2012). Maternal exposure to picrotoxin modifies the response of the GABAA receptor during sexual behavior of adult male rat offspring. Behavioural Pharmacology, 23( 7), 703-708. doi:10.1097/FBP.0b013e3283586072
NLM
Bernardi MM, Kirsten TB, Teodorov E, Baso ACZ, Prosdócimi FC, Felicio LF. Maternal exposure to picrotoxin modifies the response of the GABAA receptor during sexual behavior of adult male rat offspring [Internet]. Behavioural Pharmacology. 2012 ; 23( 7): 703-708.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0b013e3283586072
Vancouver
Bernardi MM, Kirsten TB, Teodorov E, Baso ACZ, Prosdócimi FC, Felicio LF. Maternal exposure to picrotoxin modifies the response of the GABAA receptor during sexual behavior of adult male rat offspring [Internet]. Behavioural Pharmacology. 2012 ; 23( 7): 703-708.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0b013e3283586072
Artigo de periodico
The peripheral L-arginine–nitric oxide–cyclic GMP pathway and ATP-sensitive K+ channels are involved in the antinociceptive effect of crotalphine on neuropathic pain in rats (2012)
Gutierrez, Vanessa Pacciari; Zambelli, Vanessa Olzon; Picolo, Gisele; Chacur, Marucia ; Sampaio, Sandra Coccuzzo ; Brigatte, Patricia; Konno, Katsuhiro; Cury, Yara
Fonte: Behavioural Pharmacology. Unidade: ICB
Assunto: ANATOMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUTIERREZ, Vanessa Pacciari et al. The peripheral L-arginine–nitric oxide–cyclic GMP pathway and ATP-sensitive K+ channels are involved in the antinociceptive effect of crotalphine on neuropathic pain in rats. Behavioural Pharmacology, v. 23, n. 1, p. 14-24, 2012Tradução . . Disponível em: https://doi.org/10.1097/FBP.0b013e32834eafbc. Acesso em: 26 out. 2025.
APA
Gutierrez, V. P., Zambelli, V. O., Picolo, G., Chacur, M., Sampaio, S. C., Brigatte, P., et al. (2012). The peripheral L-arginine–nitric oxide–cyclic GMP pathway and ATP-sensitive K+ channels are involved in the antinociceptive effect of crotalphine on neuropathic pain in rats. Behavioural Pharmacology, 23( 1), 14-24. doi:10.1097/FBP.0b013e32834eafbc
NLM
Gutierrez VP, Zambelli VO, Picolo G, Chacur M, Sampaio SC, Brigatte P, Konno K, Cury Y. The peripheral L-arginine–nitric oxide–cyclic GMP pathway and ATP-sensitive K+ channels are involved in the antinociceptive effect of crotalphine on neuropathic pain in rats [Internet]. Behavioural Pharmacology. 2012 ; 23( 1): 14-24.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0b013e32834eafbc
Vancouver
Gutierrez VP, Zambelli VO, Picolo G, Chacur M, Sampaio SC, Brigatte P, Konno K, Cury Y. The peripheral L-arginine–nitric oxide–cyclic GMP pathway and ATP-sensitive K+ channels are involved in the antinociceptive effect of crotalphine on neuropathic pain in rats [Internet]. Behavioural Pharmacology. 2012 ; 23( 1): 14-24.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/FBP.0b013e32834eafbc
Trabalho de evento-resumo periodico
Serotonergic 2A/2C receptors in the ventromedial hypothalamic nucleus regulate both anxiety and panic-related defensive responses in the elevated T-maze (2009)
Viana, M. B.; Silva, E. S. da; Nascimento, J. O. G.; Poltronieri, S. C.; Zangrossi Júnior, Hélio
Fonte: Behavioural Pharmacology. Nome do evento: Biennial Meeting of The European Behavioural Pharmacology Society. Unidade: FMRP
Assuntos: RECEPTORES DE SEROTONINA, PÂNICO, ANSIEDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIANA, M. B. et al. Serotonergic 2A/2C receptors in the ventromedial hypothalamic nucleus regulate both anxiety and panic-related defensive responses in the elevated T-maze. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2009
APA
Viana, M. B., Silva, E. S. da, Nascimento, J. O. G., Poltronieri, S. C., & Zangrossi Júnior, H. (2009). Serotonergic 2A/2C receptors in the ventromedial hypothalamic nucleus regulate both anxiety and panic-related defensive responses in the elevated T-maze. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Viana MB, Silva ES da, Nascimento JOG, Poltronieri SC, Zangrossi Júnior H. Serotonergic 2A/2C receptors in the ventromedial hypothalamic nucleus regulate both anxiety and panic-related defensive responses in the elevated T-maze. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Vancouver
Viana MB, Silva ES da, Nascimento JOG, Poltronieri SC, Zangrossi Júnior H. Serotonergic 2A/2C receptors in the ventromedial hypothalamic nucleus regulate both anxiety and panic-related defensive responses in the elevated T-maze. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Antagonism of TRPV1 vanilloid receptors inhibits aversive reactions induced by nitric oxide donor injected into the dorsolateral periaqueductal gray of rats (2009)
Aguiar, D. C.; Guimarães, Francisco Silveira
Fonte: Behavioural Pharmacology. Nome do evento: Biennial Meeting of The European Behavioural Pharmacology Society. Unidade: FMRP
Assuntos: ÓXIDO NÍTRICO, ANTAGONISMO DE DROGAS, SUBSTÂNCIA CINZENTA PERIAQUEDUTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGUIAR, D. C. e GUIMARÃES, Francisco Silveira. Antagonism of TRPV1 vanilloid receptors inhibits aversive reactions induced by nitric oxide donor injected into the dorsolateral periaqueductal gray of rats. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2009
APA
Aguiar, D. C., & Guimarães, F. S. (2009). Antagonism of TRPV1 vanilloid receptors inhibits aversive reactions induced by nitric oxide donor injected into the dorsolateral periaqueductal gray of rats. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Aguiar DC, Guimarães FS. Antagonism of TRPV1 vanilloid receptors inhibits aversive reactions induced by nitric oxide donor injected into the dorsolateral periaqueductal gray of rats. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Vancouver
Aguiar DC, Guimarães FS. Antagonism of TRPV1 vanilloid receptors inhibits aversive reactions induced by nitric oxide donor injected into the dorsolateral periaqueductal gray of rats. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Cannabinoid CB1 receptors located in the medial prefrontal cortex modulate the expression of contextual fear conditioning in rats (2009)
Lisboa, S. F.; Reis, D. G.; Silva, A. L. da; Corrêa, Fernando Morgan de Aguiar; Guimarães, Francisco Silveira; Resstel, L. B. M.
Fonte: Behavioural Pharmacology. Nome do evento: Biennial Meeting of The European Behavioural Pharmacology Society. Unidade: FMRP
Assuntos: CÓRTEX PRÉ-FRONTAL, NEUROTRANSMISSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LISBOA, S. F. et al. Cannabinoid CB1 receptors located in the medial prefrontal cortex modulate the expression of contextual fear conditioning in rats. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2009
APA
Lisboa, S. F., Reis, D. G., Silva, A. L. da, Corrêa, F. M. de A., Guimarães, F. S., & Resstel, L. B. M. (2009). Cannabinoid CB1 receptors located in the medial prefrontal cortex modulate the expression of contextual fear conditioning in rats. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Lisboa SF, Reis DG, Silva AL da, Corrêa FM de A, Guimarães FS, Resstel LBM. Cannabinoid CB1 receptors located in the medial prefrontal cortex modulate the expression of contextual fear conditioning in rats. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Vancouver
Lisboa SF, Reis DG, Silva AL da, Corrêa FM de A, Guimarães FS, Resstel LBM. Cannabinoid CB1 receptors located in the medial prefrontal cortex modulate the expression of contextual fear conditioning in rats. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
5-HT1A receptors in the dorsal periaqueductal gray mediate the antipanic-like effect of imipramine and fluoxetine in elavated T-maze (2009)
Zangrossi Júnior, Hélio; Bortoli, V. de; Pobbe, R.
Fonte: Behavioural Pharmacology. Nome do evento: Biennial Meeting of The European Behavioural Pharmacology Society. Unidade: FMRP
Assuntos: FARMACOLOGIA, PÂNICO, SUBSTÂNCIA CINZENTA PERIAQUEDUTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANGROSSI JÚNIOR, Hélio e BORTOLI, V. de e POBBE, R. 5-HT1A receptors in the dorsal periaqueductal gray mediate the antipanic-like effect of imipramine and fluoxetine in elavated T-maze. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2009
APA
Zangrossi Júnior, H., Bortoli, V. de, & Pobbe, R. (2009). 5-HT1A receptors in the dorsal periaqueductal gray mediate the antipanic-like effect of imipramine and fluoxetine in elavated T-maze. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Zangrossi Júnior H, Bortoli V de, Pobbe R. 5-HT1A receptors in the dorsal periaqueductal gray mediate the antipanic-like effect of imipramine and fluoxetine in elavated T-maze. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Vancouver
Zangrossi Júnior H, Bortoli V de, Pobbe R. 5-HT1A receptors in the dorsal periaqueductal gray mediate the antipanic-like effect of imipramine and fluoxetine in elavated T-maze. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Facilitation of endocannabinoid-mediated neurotransmission in the dorsal hippocampus induces anxiolytic effects in rats submitted to the vogel conflict test (2009)
Nejo, P.; Lisboa, S. F.; Guimarães, Francisco Silveira; Resstel, L. B. M.
Fonte: Behavioural Pharmacology. Nome do evento: Biennial Meeting of The European Behavioural Pharmacology Society. Unidade: FMRP
Assuntos: ANSIOLÍTICOS (EFEITOS), NEUROTRANSMISSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NEJO, P. et al. Facilitation of endocannabinoid-mediated neurotransmission in the dorsal hippocampus induces anxiolytic effects in rats submitted to the vogel conflict test. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2009
APA
Nejo, P., Lisboa, S. F., Guimarães, F. S., & Resstel, L. B. M. (2009). Facilitation of endocannabinoid-mediated neurotransmission in the dorsal hippocampus induces anxiolytic effects in rats submitted to the vogel conflict test. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Nejo P, Lisboa SF, Guimarães FS, Resstel LBM. Facilitation of endocannabinoid-mediated neurotransmission in the dorsal hippocampus induces anxiolytic effects in rats submitted to the vogel conflict test. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Vancouver
Nejo P, Lisboa SF, Guimarães FS, Resstel LBM. Facilitation of endocannabinoid-mediated neurotransmission in the dorsal hippocampus induces anxiolytic effects in rats submitted to the vogel conflict test. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Anxiolytic effects of cannabidiol injected into the dorsal periaqueductal gray of rats submitted to the elevated T-maze (2009)
Soares, V. de Paula; Campos, A. C.; Bortoli, V. C. de; Zangrossi Júnior, Hélio; Zuardi, Antonio Waldo; Guimarães, Francisco Silveira
Fonte: Behavioural Pharmacology. Nome do evento: Biennial Meeting of The European Behavioural Pharmacology Society. Unidade: FMRP
Assuntos: SUBSTÂNCIA CINZENTA PERIAQUEDUTAL, ANSIOLÍTICOS (EFEITOS), CANNABIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, V. de Paula et al. Anxiolytic effects of cannabidiol injected into the dorsal periaqueductal gray of rats submitted to the elevated T-maze. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2009
APA
Soares, V. de P., Campos, A. C., Bortoli, V. C. de, Zangrossi Júnior, H., Zuardi, A. W., & Guimarães, F. S. (2009). Anxiolytic effects of cannabidiol injected into the dorsal periaqueductal gray of rats submitted to the elevated T-maze. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Soares V de P, Campos AC, Bortoli VC de, Zangrossi Júnior H, Zuardi AW, Guimarães FS. Anxiolytic effects of cannabidiol injected into the dorsal periaqueductal gray of rats submitted to the elevated T-maze. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Vancouver
Soares V de P, Campos AC, Bortoli VC de, Zangrossi Júnior H, Zuardi AW, Guimarães FS. Anxiolytic effects of cannabidiol injected into the dorsal periaqueductal gray of rats submitted to the elevated T-maze. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Activation of 5HT1A receptors mediates the anxiolytic effects of cannabidiol in a PTSD model (2009)
Campos, A. C.; Guimarães, Francisco Silveira
Fonte: Behavioural Pharmacology. Nome do evento: Biennial Meeting of The European Behavioural Pharmacology Society. Unidade: FMRP
Assuntos: RECEPTORES, ANSIOLÍTICOS (EFEITOS), CANNABIS (PROPRIEDADES)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, A. C. e GUIMARÃES, Francisco Silveira. Activation of 5HT1A receptors mediates the anxiolytic effects of cannabidiol in a PTSD model. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2009
APA
Campos, A. C., & Guimarães, F. S. (2009). Activation of 5HT1A receptors mediates the anxiolytic effects of cannabidiol in a PTSD model. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Campos AC, Guimarães FS. Activation of 5HT1A receptors mediates the anxiolytic effects of cannabidiol in a PTSD model. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Vancouver
Campos AC, Guimarães FS. Activation of 5HT1A receptors mediates the anxiolytic effects of cannabidiol in a PTSD model. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Cannabinoid and nitrergic systems interact in the dorsolateral periaqueductal gray to modulate anxiety in rats submitted to the elevated plus maze (2009)
Lisboa, S. F.; Guimarães, Francisco Silveira
Fonte: Behavioural Pharmacology. Nome do evento: Biennial Meeting of The European Behavioural Pharmacology Society. Unidade: FMRP
Assuntos: SUBSTÂNCIA CINZENTA PERIAQUEDUTAL, ANSIOLÍTICOS (EFEITOS), ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LISBOA, S. F. e GUIMARÃES, Francisco Silveira. Cannabinoid and nitrergic systems interact in the dorsolateral periaqueductal gray to modulate anxiety in rats submitted to the elevated plus maze. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2009
APA
Lisboa, S. F., & Guimarães, F. S. (2009). Cannabinoid and nitrergic systems interact in the dorsolateral periaqueductal gray to modulate anxiety in rats submitted to the elevated plus maze. Behavioural Pharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Lisboa SF, Guimarães FS. Cannabinoid and nitrergic systems interact in the dorsolateral periaqueductal gray to modulate anxiety in rats submitted to the elevated plus maze. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Vancouver
Lisboa SF, Guimarães FS. Cannabinoid and nitrergic systems interact in the dorsolateral periaqueductal gray to modulate anxiety in rats submitted to the elevated plus maze. Behavioural Pharmacology. 2009 ; 20[citado 2025 out. 26 ]
Artigo de periodico
Effects of reversible inactivation of the dorsal hippocampus on the behavioral and cardiovascular responses to an aversive conditioned context (2008)
Resstel, Leonardo B. M.; Joca, Sâmia Regiane Lourenço; Corrêa, Fernando Morgan de Aguiar; Guimarães, Francisco Silveira
Fonte: Behavioural Pharmacology. Unidades: FCFRP, FMRP
Assuntos: HIPOCAMPU DE ANIMAL, SISTEMA CARDIOVASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RESSTEL, Leonardo B. M. et al. Effects of reversible inactivation of the dorsal hippocampus on the behavioral and cardiovascular responses to an aversive conditioned context. Behavioural Pharmacology, v. 19, n. 2, p. 137-144, 2008Tradução . . Disponível em: https://doi.org/10.1097/fbp.0b013e3282f62c9e. Acesso em: 26 out. 2025.
APA
Resstel, L. B. M., Joca, S. R. L., Corrêa, F. M. de A., & Guimarães, F. S. (2008). Effects of reversible inactivation of the dorsal hippocampus on the behavioral and cardiovascular responses to an aversive conditioned context. Behavioural Pharmacology, 19( 2), 137-144. doi:10.1097/fbp.0b013e3282f62c9e
NLM
Resstel LBM, Joca SRL, Corrêa FM de A, Guimarães FS. Effects of reversible inactivation of the dorsal hippocampus on the behavioral and cardiovascular responses to an aversive conditioned context [Internet]. Behavioural Pharmacology. 2008 ; 19( 2): 137-144.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/fbp.0b013e3282f62c9e
Vancouver
Resstel LBM, Joca SRL, Corrêa FM de A, Guimarães FS. Effects of reversible inactivation of the dorsal hippocampus on the behavioral and cardiovascular responses to an aversive conditioned context [Internet]. Behavioural Pharmacology. 2008 ; 19( 2): 137-144.[citado 2025 out. 26 ] Available from: https://doi.org/10.1097/fbp.0b013e3282f62c9e

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Indexado em

Afiliação dos autores externos não normalizada